Repurposing anticancer drugs for the management of COVID-19

Since its outbreak in the last December, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has rapidly spread worldwide at a pandemic proportion and thus is regarded as a global public health emergency. The existing therapeutic options for COVID-19 beyond the intensive supportive care are lim...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur J Cancer
Prif Awduron: El Bairi, Khalid, Trapani, Dario, Petrillo, Angelica, Le Page, Cécile, Zbakh, Hanaa, Daniele, Bruno, Belbaraka, Rhizlane, Curigliano, Giuseppe, Afqir, Said
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier Ltd. 2020
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7508523/
https://ncbi.nlm.nih.gov/pubmed/33125946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2020.09.014
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg